Bharat Book Bureau Provides the Trending Market Research Report on Global InVitro Diagnostics Market Opportunity Analysis and Industry Forecast 2017-2023 Under Life Science category. The report provides information on industry overview, market size, latest developments, industry trends, key players, global presence, and their future prospects.
InVitro Diagnostics Market : In Vitro Diagnostics Market : Invitro diagnostics are used to detect and diagnose diseases such as blood, tissue, urine, stools and other bodily fluids. Various technologies are incorporated in in vitro diagnostics such as microarray techniques, mass spectrometry, polymerase chain reaction and sequencing technology are used for testing the sample preparation.
Market Outline: Global In Vitro Diagnostics Market
There is a growing demand for diagnostic tools for the diagnosis of diagnostic disorders. Rising adaptation of point of care testing, rising incidences of lifestyle diseases are expected to boost the market. As reported by National Diabetes Statistics states that about 9.3% of US population have diabetes and about 8.1 million people are undiagnosed, in accordance with WHO, about 5 million deaths were recorded because of the chronic diseases like TB, malaria, and AIDS in 2011 , around 8.7 Mn cases registered due to TB. Cancer accounted for 7.9Mn deaths and anticipated to reach 11Mn by 2030. Increase in the number of laboratories with sophisticated infrastructure in developed countries is the few factors expected to boost the growth of Invitro diagnostics market. However, unfavorable reimbursement policies in developing countries and strict regulatory frameworks are the factors that are restraining the growth of the IVD market.
Request a free sample copy of InVitro Diagnostics Market Report @
https://www.bharatbook.com/request-sample/626419
The InVitro Diagnostics (IVD) market is classified as the basis of product type, application, techniques, end user and geography.
Based on product type, in vitro diagnostics market is segmented into the Following
– Reagents and consumables
– Instruments
Based on techniques, in vitro diagnostics market is segmented into the Following
– Immunochemistry
– Molecular diagnostics
– Clinical Chemistry
– Tissue diagnostics
– Hemostasis and Coagulation
– Others
Based on Application, Invitro diagnostics (IVD) market is segmented into the following
– Cancer
– Infectious diseases
– Nephrological diseases
– Immune system disorders
– Gastrointestinal disorders
– Neurological disorders
– Hematological disorders
– Others
Based on end user, Invitro diagnostics market is segmented into the following
– Hospitals
– Diagnostic Centers
– Point-of-care testing
– Others
Players in Invitro diagnostics are focusing on acquisitions, exclusive agreements and strategic collaborations in order to expand their business. In February 2015, Roche has acquired Signature Diagnostics to strengthen its cancer diagnostics. In February 2014, Thermo Fisher Scientific has acquired Life Technologies Corporation to strengthen it’s next-generation sequencing space segment. Different organizations are being employed in order to monitor the industry. For example, BIVDA (British In Vitro Diagnostics Association) is an association of various companies in the UK which represents the manufacturers and distributors with high interest and involvement. Recently, Life Technology Corporation has launched CE-IVD Marked QuantStudio Dx Real-Time PCR instrument.
On the basis of geographical regions, Invitro Diagnostics is classified as Europe, Asia-Pacific, North America, Europe, Middle East & Africa and Latin America. IVD market is the largest market with the highest share of the IVD market, which is following the prevalence of chronic genetic and lifestyle diseases. Asia-Pacific is expected to show the fastest growth rate and therefore wants to emerge as the area with potential for increasing the growth of the healthcare infrastructure and growing economies in India and China.
The key players in this market are Becton, Dickinson and Company (US), Abbott Laboratories (US), Danaher Corporation (US), Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Thermo Fisher Scientific, Inc. (US), Sysmex Corporation (Japan), bioMérieux (France), Bio-Rad Laboratories, Inc. (US), Qiagen NV (Germany), Diasorin SPA (Italy), Ortho-Clinical Diagnostics, Inc. (US), and Johnson and Johnson ( US).
In April 2015, Abbott and Sekisui entered into an agreement on providing solutions for coagulation testing for laboratories across the world.
In December 2014, Roche expanded its CE-IVD for testing of human organ and tissue for next-gen blood screening assays. cobas MPX and Cobas WNV assays can be used to test tissue and human organ, thus expanding the range of approved uses for the cobas 6800/8800 systems and assays.
Browse our full report with Table of Contents:
https://www.bharatbook.com/medical-devices-market-research-reports-626419/invitro-diagnostics-ivd.html
About Bharat Book Bureau:
Bharat Book Bureau is a leading research information provider for market research reports, company profiles, industry reports, country reports, business reports, newsletters and online databases. Bharat Book Bureau delivers more than 400 publishers around the globe. We cover ourselves from Aeronautics to Zoology.
Contact us at:
Bharat Book Bureau
Tel : +91 22 27810772/27810773
Email : poonam@bharatbook.com
Website : www.bharatbook.com
Follow us on : Twitter, Facebook, LinkedIn, Google Plus